Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

Stanley B. Cohen; Robin K. Dore; Nancy E. Lane; Peter A. Ory; Charles G. Peterfy; John T. Sharp; Désirée van der Heijde; Lifen Zhou; Wayne Tsuji; Richard Newmark;

doi:10.1002/art.23417

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

Arthritis & Rheumatism ◽

10.1002/art.23417 ◽

2008 ◽

Vol 58 (5) ◽

pp. 1299-1309 ◽

Cited By ~ 398

Author(s):

Stanley B. Cohen ◽

Robin K. Dore ◽

Nancy E. Lane ◽

Peter A. Ory ◽

Charles G. Peterfy ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Bone Mineral Density ◽

Clinical Trial ◽

Bone Turnover ◽

Phase Ii ◽

Structural Damage ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Denosumab Treatment

Download Full-text

Denosumab Treatment Effects on Structural Damage, Bone Mineral Density, and Bone Turnover in Rheumatoid Arthritis: A Twelve-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial

Yearbook of Medicine ◽

10.1016/s0084-3873(09)79332-0 ◽

2009 ◽

Vol 2009 ◽

pp. 12-13

Author(s):

N. Cotter

Keyword(s):

Rheumatoid Arthritis ◽

Bone Mineral Density ◽

Clinical Trial ◽

Bone Turnover ◽

Phase Ii ◽

Structural Damage ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Denosumab Treatment

Download Full-text

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: A multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.09.017 ◽

2007 ◽

Vol 29 (9) ◽

pp. 1937-1949 ◽

Cited By ~ 12

Author(s):

M VALIMAIKI ◽

J FARRERONSMINGUELLA ◽

J HALSE ◽

H KROGER ◽

M MARONI ◽

...

Keyword(s):

Bone Mineral Density ◽

Bone Turnover ◽

Bone Turnover Markers ◽

Phase Iii ◽

Mineral Density ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Parallel Group ◽

Turnover Markers

Download Full-text

Effect of vitamin D therapy on bone mineral density in patients with diabetic nephropathy; a randomized, double-blind placebo controlled clinical trial

Journal of Diabetes & Metabolic Disorders ◽

10.1007/s40200-021-00737-y ◽

2021 ◽

Author(s):

Gayani Liyanage ◽

Sarath Lekamwasam ◽

Thilak Weerarathna ◽

Chandrani Liyanage

Keyword(s):

Bone Mineral Density ◽

Clinical Trial ◽

Vitamin D ◽

Diabetic Nephropathy ◽

Bone Mineral ◽

Controlled Clinical Trial ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725949928.793558766 ◽

2019 ◽

Author(s):

Sakae Tanaka

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Phase Ii ◽

Dose Response ◽

Bone Erosion ◽

Japanese Patients ◽

Inhibitory Effect ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Response Study

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate (ALN) on Bone Mineral Density (BMD) and Bone Turnover in Perimenopausal Women With Low BMD

Journal of Clinical Densitometry ◽

10.1016/j.jocd.2014.04.095 ◽

2014 ◽

Vol 17 (3) ◽

pp. 425-426

Author(s):

A. Khan ◽

S. Dubois ◽

Z. Rahman ◽

O.A. Khan ◽

C. Derzko

Keyword(s):

Bone Mineral Density ◽

Bone Turnover ◽

Bone Mineral ◽

Controlled Study ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Perimenopausal Women

Download Full-text

The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm.2007.352 ◽

2007 ◽

Vol 45 (12) ◽

Cited By ~ 21

Author(s):

Markus Herrmann ◽

Natalia Umanskaya ◽

Lydia Traber ◽

Heinrich Schmidt-Gayk ◽

Wolfgang Menke ◽

...

Keyword(s):

Bone Mineral Density ◽

Bone Turnover ◽

Bone Mineral ◽

Bone Turnover Markers ◽

Controlled Trial ◽

B Vitamins ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Turnover Markers

AbstractClin Chem Lab Med 2007;45:1785–92.

Download Full-text

Potential benefits of Nigella sativa oil supplementation on asthma inflammation: a randomised, double-blind, placebo-controlled, exploratory phase-II clinical trial

Planta Medica ◽

10.1055/s-0036-1596928 ◽

2016 ◽

Vol 81 (S 01) ◽

pp. S1-S381

Author(s):

A Koshak ◽

L Wei ◽

E Koshak ◽

S Wali ◽

O Alamoudi ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Nigella Sativa ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Potential Benefits

Download Full-text

Faculty Opinions recommendation of Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1050659.502564 ◽

2006 ◽

Author(s):

Henry Burger

Keyword(s):

Bone Mineral Density ◽

Anorexia Nervosa ◽

Oral Contraceptive ◽

Bone Mineral ◽

Ethinyl Estradiol ◽

Adolescent Females ◽

Controlled Study ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1229980.697084 ◽

2009 ◽

Author(s):

Martin Aringer ◽

Alexander Kleymann

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The Effects of Rasagiline on Glucose Metabolism and Cognition and Their Relationship to Tau Burden in a Double-Blind, Placebo-Controlled Phase Ii Clinical Trial of Participants with Alzheimer's Dementia

SSRN Electronic Journal ◽

10.2139/ssrn.3544838 ◽

2020 ◽

Author(s):

Dawn Matthews ◽

Aaron Ritter ◽

Ronald G. Thomas ◽

Randolph D. Andrews ◽

Ana S. Lukic ◽

...

Keyword(s):

Clinical Trial ◽

Glucose Metabolism ◽

Phase Ii ◽

Alzheimer’S Dementia ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Alzheimer's Dementia ◽

Double Blind Placebo

Download Full-text